Atmo Biosciences ^Company

Atmo is a clinical stage digital health business focussed on empowering researchers, clinicians and patients with objective real-time insights into gut health and microbiome function. Atmo addresses the unmet clinical need to monitor microbiome function, allowing better diagnosis and management of personalised therapies for gastrointestinal disorders, resulting in improved gut health and wellness. The company is underpinned by a world-first ingestible gas-sensing capsule + cloud platform, which continuously measures clinically important gaseous biomarkers during transit through the gut and transmits the data wirelessly to the cloud for aggregation and analysis, to determine gut health or dysfunction, resulting in earlier relief of symptoms through personalised therapeutic approaches.